EU approves use of implantable defibrillator

The US firm Boston Scientific reports that it has received the Conformité Européenne (CE) Mark for its Confient implantable cardioverter defibrillator (ICD), the company's first branded cardiac rhythm management device to treat sudden cardiac death. Containing wireless capability, the Confient ICD has been designed to reduce right ventricular pacing.


Read all latest stories

Related articles


Article •

The 75th DGK Congress

In April, the 75th annual congress of the German Cardiac Society (DGK) was considered a great success, drawing in some 7,900 specialists.

Article •

HeartVue 6S seeks USA marketing

Pegasus/Heartview LLC has announced that clinical studies of its HeartVue 6S Heart Screening System - which obtained CE Mark Approval in Europe almost two years ago - have been completed according to…


News • Myocardial infarction, heart failure, atrial fibrillation, and aortic stenosis

Research reveals striking inequalities in NHS heart care

Stark inequalities in diagnosis and treatment of four of the most common heart conditions in the UK have been revealed in new research led by a team at the University of Leeds.

Related products

Subscribe to Newsletter